![[Avant] Ensemble roulement de roue et moyeu pour Saturn Vue Chevrolet Equinox Pontiac K77-102345 2022-bmw-m3 Numéro de pièce: KC8-102228N KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/K77-102345-01.jpg?v=1773904961)
[Avant] Ensemble roulement de roue et moyeu pour Saturn Vue Chevrolet Equinox Pontiac K77-102345 2022-bmw-m3 Numéro de pièce: KC8-102228N KDA-100498
EUR166.03EUR195.03
Pay in 4 interest-free payments of $41.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Harbor notes
Description
[Avant] Ensemble roulement de roue et moyeu pour Saturn Vue Chevrolet Equinox Pontiac K77 102345 2022 bmw m3 Numéro de pièce: KC8 102228N KDA 100498 Numéro de pièce: KC8 102228N Pièces interchangeables OEM: 531 247 TI81220 GEV80645 MEV80645 EV80645 ES80645 2693606 401 2269 TEV80645 JAR1218 89180002 531 218 TO81125 TO81415 TO82225 GS25604 ES25610 MES3614 MS25604 MS25610 ES3614 ES800408 2693277 401 1940 TES3614 TES800408 JTE1516 89180017 Produit: Ensemble roulement de roue et moyeu 2002 Saturn Vue
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant] Ensemble roulement de roue et moyeu pour Saturn Vue Chevrolet Equinox Pontiac K77-102345 2022-bmw-m3 Numéro de pièce: KC8-102228N KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.